TD Cowen Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Joshua Jennings maintains a Buy rating on PROCEPT BioRobotics (NASDAQ:PRCT) and raises the price target from $65 to $75.
May 06, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen reaffirms a Buy rating on PROCEPT BioRobotics and increases the price target to $75.
The upgrade in price target by a reputable analyst like Joshua Jennings from TD Cowen is a strong positive signal for investors, indicating a bullish outlook on PROCEPT BioRobotics. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100